1	HIV	HIV	_	_	_	_	_	_	_
2	type	type	_	_	_	_	_	_	_
3	1	1	_	_	_	_	_	_	_
4	protease	protease	_	_	_	_	_	_	_
5	activation	activation	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	NF-kappa	NF-kappa	_	_	_	_	_	_	_
8	B	B	_	_	_	_	_	_	_
9	within	within	_	_	_	_	_	_	_
10	T	t	_	_	_	_	_	_	_
11	lymphoid	lymphoid	_	_	_	_	_	_	_
12	cells	cell	_	_	_	_	_	_	_
13	.	.	_	_	_	_	_	_	_

1	NF-kappa	NF-kappa	_	_	_	_	_	_	_
2	B	B	_	_	_	_	_	_	_
3	is	be	_	_	_	_	_	_	_
4	a	a	_	_	_	_	_	_	_
5	nuclear	nuclear	_	_	_	_	_	_	_
6	protein	protein	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	rel	rel	_	_	_	_	_	_	_
10	oncogene	oncogene	_	_	_	_	_	_	_
11	family	family	_	_	_	_	_	_	_
12	capable	capable	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	enhancing	enhance	_	_	_	_	_	_	_
15	transcription	transcription	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	several	several	_	_	_	_	_	_	_
18	cellular	cellular	_	_	_	_	_	_	_
19	genes	gene	_	_	_	_	_	_	_
20	,	,	_	_	_	_	_	_	_
21	including	include	_	_	_	_	_	_	_
22	IL-2	il-2	_	_	_	_	_	_	_
23	and	and	_	_	_	_	_	_	_
24	the	the	_	_	_	_	_	_	_
25	IL-2	il-2	_	_	_	_	_	_	_
26	receptor	receptor	_	_	_	_	_	_	_
27	,	,	_	_	_	_	_	_	_
28	and	and	_	_	_	_	_	_	_
29	viral	viral	_	_	_	_	_	_	_
30	genes	gene	_	_	_	_	_	_	_
31	transcribed	transcribe	_	_	_	_	_	_	_
32	from	from	_	_	_	_	_	_	_
33	the	the	_	_	_	_	_	_	_
34	HIV-1	HIV-1	_	_	_	_	_	_	_
35	LTR	LTR	_	_	_	_	_	_	_
36	.	.	_	_	_	_	_	_	_

1	It	it	_	_	_	_	_	_	_
2	has	have	_	_	_	_	_	_	_
3	been	be	_	_	_	_	_	_	_
4	reported	report	_	_	_	_	_	_	_
5	that	that	_	_	_	_	_	_	_
6	HIV-1	HIV-1	_	_	_	_	_	_	_
7	protease	protease	_	_	_	_	_	_	_
8	may	may	_	_	_	_	_	_	_
9	cleave	cleave	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	NF-kappa	NF-kappa	_	_	_	_	_	_	_
12	B	B	_	_	_	_	_	_	_
13	precursor	precursor	_	_	_	_	_	_	_
14	to	to	_	_	_	_	_	_	_
15	its	its	_	_	_	_	_	_	_
16	active	active	_	_	_	_	_	_	_
17	form	form	_	_	_	_	_	_	_
18	in	in	_	_	_	_	_	_	_
19	vitro	vitro	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	this	this	_	_	_	_	_	_	_
3	study	study	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	effects	effect	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	HIV	HIV	_	_	_	_	_	_	_
8	protease	protease	_	_	_	_	_	_	_
9	on	on	_	_	_	_	_	_	_
10	NF-kappa	NF-kappa	_	_	_	_	_	_	_
11	B	B	_	_	_	_	_	_	_
12	precursor	precursor	_	_	_	_	_	_	_
13	activation	activation	_	_	_	_	_	_	_
14	were	be	_	_	_	_	_	_	_
15	examined	examine	_	_	_	_	_	_	_
16	in	in	_	_	_	_	_	_	_
17	Jurkat	Jurkat	_	_	_	_	_	_	_
18	T	t	_	_	_	_	_	_	_
19	cells	cell	_	_	_	_	_	_	_
20	by	by	_	_	_	_	_	_	_
21	introducing	introduce	_	_	_	_	_	_	_
22	a	a	_	_	_	_	_	_	_
23	protease	protease	_	_	_	_	_	_	_
24	expression	expression	_	_	_	_	_	_	_
25	vector	vector	_	_	_	_	_	_	_
26	into	into	_	_	_	_	_	_	_
27	the	the	_	_	_	_	_	_	_
28	cells	cell	_	_	_	_	_	_	_
29	.	.	_	_	_	_	_	_	_

1	Increased	increase	_	_	_	_	_	_	_
2	NF-kappa	NF-kappa	_	_	_	_	_	_	_
3	B	B	_	_	_	_	_	_	_
4	activity	activity	_	_	_	_	_	_	_
5	was	be	_	_	_	_	_	_	_
6	observed	observe	_	_	_	_	_	_	_
7	and	and	_	_	_	_	_	_	_
8	this	this	_	_	_	_	_	_	_
9	increased	increase	_	_	_	_	_	_	_
10	activity	activity	_	_	_	_	_	_	_
11	was	be	_	_	_	_	_	_	_
12	blocked	block	_	_	_	_	_	_	_
13	by	by	_	_	_	_	_	_	_
14	a	a	_	_	_	_	_	_	_
15	specific	specific	_	_	_	_	_	_	_
16	inhibitor	inhibitor	_	_	_	_	_	_	_
17	of	of	_	_	_	_	_	_	_
18	the	the	_	_	_	_	_	_	_
19	viral	viral	_	_	_	_	_	_	_
20	protease	protease	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	Viral	viral	_	_	_	_	_	_	_
2	transcription	transcription	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	as	as	_	_	_	_	_	_	_
5	measured	measure	_	_	_	_	_	_	_
6	using	use	_	_	_	_	_	_	_
7	LTR-CAT	LTR-CAT	_	_	_	_	_	_	_
8	assays	assay	_	_	_	_	_	_	_
9	,	,	_	_	_	_	_	_	_
10	was	be	_	_	_	_	_	_	_
11	only	only	_	_	_	_	_	_	_
12	slightly	slightly	_	_	_	_	_	_	_
13	enhanced	enhance	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	HIV-protease	hiv-protease	_	_	_	_	_	_	_
17	expressing	express	_	_	_	_	_	_	_
18	cells	cell	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	while	while	_	_	_	_	_	_	_
21	secretion	secretion	_	_	_	_	_	_	_
22	of	of	_	_	_	_	_	_	_
23	IL-2	il-2	_	_	_	_	_	_	_
24	and	and	_	_	_	_	_	_	_
25	expression	expression	_	_	_	_	_	_	_
26	of	of	_	_	_	_	_	_	_
27	the	the	_	_	_	_	_	_	_
28	IL-2	il-2	_	_	_	_	_	_	_
29	receptor	receptor	_	_	_	_	_	_	_
30	were	be	_	_	_	_	_	_	_
31	not	not	_	_	_	_	_	_	_
32	affected	affect	_	_	_	_	_	_	_
33	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	limited	limited	_	_	_	_	_	_	_
3	activation	activation	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	NF-kappa	NF-kappa	_	_	_	_	_	_	_
6	B	B	_	_	_	_	_	_	_
7	by	by	_	_	_	_	_	_	_
8	HIV	HIV	_	_	_	_	_	_	_
9	protease	protease	_	_	_	_	_	_	_
10	appears	appear	_	_	_	_	_	_	_
11	unlikely	unlikely	_	_	_	_	_	_	_
12	to	to	_	_	_	_	_	_	_
13	have	have	_	_	_	_	_	_	_
14	a	a	_	_	_	_	_	_	_
15	significant	significant	_	_	_	_	_	_	_
16	effect	effect	_	_	_	_	_	_	_
17	on	on	_	_	_	_	_	_	_
18	virus	virus	_	_	_	_	_	_	_
19	expression	expression	_	_	_	_	_	_	_
20	or	or	_	_	_	_	_	_	_
21	T	t	_	_	_	_	_	_	_
22	cell	cell	_	_	_	_	_	_	_
23	function	function	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

